X-Linked Mental Retardation Gene CUL4B Targets Ubiquitylation of H3K4 Methyltransferase Component WDR5 and Regulates Neuronal Gene Expression by Nakagawa, Tadashi & Xiong, Yue
X-Linked Mental Retardation Gene Product CUL4B Targets
Ubiquitylation of H3K4 Methyltransferase Core Component
WDR5 and Regulates Neuronal Gene Expression
Tadashi Nakagawa1,2 and Yue Xiong1,2,3,*
1Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel
Hill, NC 27599, USA
2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel
Hill, NC 27599, USA
3Program in Molecular Biology and Biotechnology, University of North Carolina at Chapel Hill,
Chapel Hill, NC 27599, USA
SUMMARY
CUL4B, encoding a scaffold protein for the assembly of Cullin4B-Ring ubiquitin ligase (CRL4B)
complexes, is frequently mutated in X-linked mental retardation (XLMR) patients. Here, we show
that CUL4B, but not its paralogue CUL4A, targets WDR5, a core subunit of histone H3 lysine 4
(H3K4) methyltransferase complexes, for ubiquitination and degradation in the nucleus. Knocking
down CUL4B increases WDR5 and trimethylated H3K4 (H3K4me3) on the neuronal gene
promoters and induces their expression. Furthermore, CUL4B depletion suppresses neurite
outgrowth of PC12 neuroendocrine cells which can be rescued by co-depletion of WDR5. XLMR-
linked mutations destabilize CUL4B and impair its ability to support neurite outgrowth of PC12
cells. Our results identify WDR5 as a critical substrate of CUL4B in regulating neuronal gene
expression and suggest epigenetic change as a common pathogenic mechanism for CUL4B-
associated XLMR.
INTRODUCTION
The ubiquitin system covalently attaches ubiquitin to specific substrate proteins, resulting in
either an alteration of substrate function or, more commonly, degradation by the 26S
proteasome (Pickart, 2001). Disruption of this system has been linked to the development of
various types of human diseases, including autoimmunity (Bhoj and Chen, 2009),
neurological diseases (Tai and Schuman, 2008; Yi and Ehlers, 2007) and cancer (Frescas
and Pagano, 2008; Nakayama and Nakayama, 2006). Ubiquitylation begins with the ATP
dependent activation of ubiquitin by the E1 enzyme, is followed by the transfer of activated
ubiquitin to an E2 ubiquitin conjugating enzyme, and finally an E3 ubiquitin ligase is
responsible for recruiting a specific substrate and promoting ubiquitin ligation. Over 1,000
distinct E3 ligases, belonging to two major families, the HECT family and the RING family,
are present in higher eukaryotes, implicating a very broad function of the ubiquitin system in
cell regulation. Although not containing a RING domain intrinsically themselves, members
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of the evolutionarily conserved cullin family can bind with a small RING protein, either
ROC1 or ROC2 (for RING of Cullins; also known as Rbx and Hrt1), in trans to constitute
by far the largest family of E3 ligases, the cullin-RING ligases (CRLs). Unlike other RING
E3 ligases, cullins do not bind substrates directly, but rather rely on substrate recruiting
receptors that are typically joined to the cullin complex by a linker protein. Remarkably,
each cullin can associate with a different family of substrate receptors, potentially
constituting as many as 300 – 500 distinct CRLs in vivo (Zimmerman et al., 2010).
CUL4 is one of three founding cullins evolutionarily conserved from yeast to humans.
Genetic analyses in various organisms have revealed a wide range of cellular and organismal
functions of CUL4, many of which are associated with chromatin such as chromosome
condensation, heterochromatin formation, DNA replication and repair (O'Connell and
Harper, 2007, Jackson, 2009 #2638). CUL4 presents as a single gene in yeast, plant and
invertebrate, but vertebrates express two closely related paralogues, CUL4A and CUL4B.
Deletion of Cul4a in mice increased levels of several CRL4 substrates, but did not cause
major developmental defects or obvious pathological conditions, (Liu et al., 2009). Cul4b
deficiency, on the other hand, resulted in embryonic lethality around E9.5 and defects in
nervous system and heart development (Cox et al.), indicating a unique function of Cul4b
that cannot be compensated by Cul4a. In human, CUL4A gene amplification is noted in
human breast (Chen et al., 1998), liver cancers (Yasui et al., 2002) and pleural mesothelioma
(Hung et al., 2009), whereas loss-of-function mutations in CUL4B have been identified in
patients with X-linked mental retardation (XLMR) (Badura-Stronka et al., 2010; Isidor et
al., 2010; Tarpey et al., 2007; Zou et al., 2007).
Mental retardation (MR) affects approximately 1–3% of the population in the United States
(Leonard and Wen, 2002). Genetic factors contribute to a high percentage of severe MR
cases, and nearly 300 MR genes have been identified. Among them, about 16% of genes are
X-linked genes and affect primarily males (Inlow and Restifo, 2004), leading to XLMR
(Chiurazzi et al., 2008; Ropers, 2006), including CUL4B which was identified by a recent
chromosome-wide whole exon sequencing study to be one of the most frequently mutated
genes in XLMR patients. The molecular mechanisms by which CUL4 regulates chromatin
and CUL4B mutations contribute to XLMR are unclear. This study is directed toward these
issues.
RESULTS
WDR5 is degraded by DDB1-CUL4B E3 ubiquitin ligase
Previously, we and other groups reported that human cells express as many as ninety DDB1-
binding WD40 proteins (DWD, also known as DCAF for DDB1- and CUL4-associated
factors and CDW for CUL4 and DDB1-associated WD40 repeats) (Angers et al., 2006; He
et al., 2006; Higa et al., 2006; Jin et al., 2006). Among these DWD proteins is WDR5, a core
subunit of histone H3 lysine 4 (H3K4) methyltransferase complexes (Dou et al., 2006;
Trievel and Shilatifard, 2009). Although DWD/DCAF/CDW proteins are believed to
function as substrate recognition subunits in CRL4s, we found surprisingly that knocking
down DDB1 increased the steady state level of WDR5 protein in either HCT116 (Figure
1A) or HeLa cells (Figure S1A), but had little effect on the level of WDR5 mRNA (Figure
1B). These results suggest that the increase in WDR5 level is achieved via a
posttranscriptional mechanism and that WDR5 may be itself a substrate of DDB1-based E3
ligase.
DDB1 functions as a linker for both CUL4A and CUL4B ubiquitin ligase complexes. To
determine which CUL4 was responsible for the destabilization of WDR5, we treated cells
with siRNA targeting CUL4A, CUL4B or combination of both CUL4A and CUL4B, and
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determined the level of WDR5. We found that knocking down CUL4B, but not CUL4A,
increased WDR5 as much as knocking down DDB1 in both HCT116 (Figure 1C) and HeLa
cells (Figure S1B), but had little effect on WDR5 mRNA level (Figure 1B). In contrast,
RBBP5, another DWD protein and also a core subunit of H3K4 methyltransferase
complexes, was not stabilized in DDB1 or CUL4B knockdown cells. Knocking down DDB1
had little effect on the steady state levels of three other DWD proteins (EED, BRWD3 and
WDR61) and three XLMR proteins (FMR1, ATRX, BRWD3, Figure S1D), indicating a
specificity of DDB1-CUL4B-targeted WDR5 degradation. Cycloheximide chase experiment
demonstrates that WDR5 is a unstable protein, with an half-life of about 8 hours, but was
stabilized by the CUL4B depletion (Figure 1D). To further confirm the specificity of
CUL4B-DDB1 mediated WDR5 degradation, we transiently overexpressed myc-tagged
cullin family proteins (CUL1, 2, 3, 4A, 4B, 5, and 7) in HCT116 or 293T cells. The ectopic
expression of CUL4B, but not the other 6 cullins, reduced WDR5 in HCT116 cells to a
barely-detectable low level (Figure 1E), which was inhibited by proteasome inhibitor
treatment (Figure 1F), indicating a CUL4B- and DDB1-promoted, proteosome-dependent
degradation of WDR5. In 293T cells, however, not only CUL4B but also CUL1
overexpression decreased WDR5 (Figure S1C), suggesting the possibility that in different
cell types, WDR5 may be regulated by multiple E3 ligases. We did not investigate further
CUL1-mediated WDR5 degradation and instead focused this study on elucidating the
mechanism and significance in XLMR development of CUL4B-mediated WDR5
degradation.
WDR5 is ubiquitylated by CRL4B E3 ubiquitin ligase in vivo and in vitro
To further determine the hypothesis that WDR5 is a substrate of CRL4B, we performed both
in vivo and in vitro ubiquitination assays. HCT116 cells were transiently transfected with
either myc-tagged CUL4A or CUL4B alone with hemagglutinin (HA)-tagged ubiquitin and
WDR5 was immunoprecipitated under a denaturing condition, followed by direct
immunoblotting analyses. This experiment revealed that endogenous WDR5 is ubiquitinated
in vivo, which is enhanced by either CUL4A or CUL4B overexpression with the latter being
more potent (Figure 2A). Conversely, to demonstrate WDR5 ubiquitylation by CUL4B-
DDB1 in a more physiological settings, we transfected HCT116 cells with siRNA targeting
DDB1, CUL4A or CUL4B, followed by transient transfection of HA-ubiquitin and in vivo
ubiquitylation assay. Although CUL4A knockdown did not affect the ubiquitylation of
endogenous WDR5, DDB1 and CUL4B knockdown, both efficiently inhibited the
ubiquitylation of endogenous WDR5 (Figure 2B). To directly test whether WDR5 is a
substrate of CRL4B, we set up the in vitro ubiquitination assay and found that WDR5 is
ubiquitinated by CRL4B in a E1-, E2- and E3(CRL4B)-dependent manner (Figure 2C).
Next, we determined the binding of endogenous WDR5 with CUL4 proteins and detected a
clear association of WDR5 with CUL4B, but not CUL4A in HCT116 cells after treatment
with a proteasome inhibitor (Figure 2D). To determine whether the CUL4B-WDR5
association is bridged by DDB1, we constructed a CUL4B mutant which harbors four amino
acids substitution in the H5 helix region (293WQNH296 to 293AAAA296, Figure S5A), that
are invariably conserved in orthologues, but are different in paralogues and required for
interact with linker proteins (Zheng et al., 2002). Like the mutation in the H5 helix of
CUL4A which disrupted its binding with DDB1 (Hu et al., 2004), the mutation in the H5
helix of CUL4B also completely disrupted its binding to not only DDB1 but also WDR5
(Figure 2E). Taken together, these results demonstrate that DDB1 recruits WDR5 to the
CUL4B-ROC1 E3 ligase for ubiquitylation.
Nuclear localization is critical for CRL4B to degrade WDR5
Human CUL4A and CUL4B share 80% amino acid identity throughout the entire sequences
and are often functionally redundant. It is therefore intriguing to see that WDR5 is only
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ubiquitylated by CUL4B, but not CUL4A. To determine the structural basis of this
difference, we noted that CUL4B contains a unique N-terminal sequence that contains a
putative nuclear localization signal (NLS, 55KKRK58, Figure S5A), and is not present in
CUL4A (Figure 3A), which is also reported by another group recently (Zou et al., 2009).
Given that WDR5 is also localized in the nucleus [(Wysocka et al., 2005), and our
confirmatory result in Figure 3E], we tested the possibility that CUL4B specifically targets
WDR5 degradation in the nucleus. We constructed NLS mutant of CUL4B (K56A/R57A)
and found that while wild type CUL4B is localized predominantly in the nucleus, the
CUL4BK56A/R57A is localized mainly in the cytoplasm (Figure 3B). Importantly,
overexpression of NLS mutant CUL4BK56A/R57A failed to degrade WDR5 and instead
increased WDR5 level (Figure 3C), indicative of possible dominant negative effect over the
endogenous wild type CUL4B. Conversely, to test whether the lack of NLS in CUL4A is
responsible for its inability to degrade WDR5, we transplanted N-terminal 60 amino acids
from CUL4B containing the NLS to the N-terminus of CUL4A. We found that fusion with
this 60-mer sequence (Myc-CUL4A-NLS), but not the same 60-mer containing K56A/R57A
substitution in the NLS (NLS mut), conferred CUL4A the ability to promote WDR5
degradation (Figure 3D). Finally, we separated PC12 lysate into nuclear and cytosolic
fractions, and found that while CUL4B is localized in both the nucleus and the cytoplasm,
CUL4A is localized predominantly in the cytoplasm (Figure 3E). A stronger CUL4B-WDR5
association was seen in the nuclear fraction (Figure 3F). In contrast, RBBP5, although also
enriched in the nucleus, did not bind to CUL4B. Together, these results demonstrate that
CUL4B, but not CUL4A, is localized in the nucleus, binds to and targets nuclear localized
WDR5 for degradation.
CUL4B regulates neuronal gene expression through H3K4 modification in a WDR5
dependent manner
In searching for the mechanism underlying the contribution of CUL4B mutations to the
development of XLMR, we noted that another XLMR gene product, KDM5C/SMCX/
JARID1C, is a H3K4 demethylase and its demethylase activity is abolished or reduced by
XLMR mutations, leading to the abnormal activation of a group of neuronal genes (Iwase et
al., 2007; Tahiliani et al., 2007). Given the critical function of WDR5 for the H3K4
methylation by MLL1 and other related methyltransferases, we hypothesized that CUL4B
mutation may contribute to XLMR development similarly because of abnormal
accumulation of WDR5 and activation of neuronal genes. To test this hypothesis, we
transduced HeLa cells with retrovirus expressing encoding control (GFP) or CUL4B
shRNA, and performed chromatin immunoprecipitation (ChIP) analyses with WDR5,
RBBP5 or H3K4me3 antibodies. Stable knockdown of CUL4B increased the steady state
level of WDR5 protein, the binding of both WDR5 and RBBP5 and H3K4me3 on several
neuronal gene promoters (Figures 4A, 4B and S4A), but not the binding to a control gene,
ARF tumor suppressor which is known to be activated by H3K4 methylation in a WDR5-
dependent manner following stimulation by oncogene E7 (Kotake et al., 2009). Next, we
examined whether expression of these neuronal genes are induced by CUL4B knockdown.
To this end, we isolated RNA from control (GFP) or CUL4B knockdown cells and
performed quantitative reverse-transcribed PCR (qRT-PCR) analyses. Consistent with the
ChIP assay, mRNA levels of these neuronal genes were increased in CUL4B knockdown
cells (Figure 4C). Importantly, these phenotypes are suppressed by simultaneous knocking-
down of WDR5 (Figures 4A, 4B and 4C). Furthermore, global level of H3K4me3 was also
increased after CUL4B knocking down in WDR5 dependent manner (Figure 4B). Taken
together, these results suggest that CUL4B negatively regulates H3K4me3 level by
degrading WDR5 and controls the expression of neuronal genes.
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Cul4b regulates NGF-induced neurite extension of PC12 cells in a Wdr5 dependent manner
Exact cellular phenotypes caused by XLMR mutations are yet to be defined and are likely
multifaceted. However, a previous study showed that reduced expression of XLMR gene
JARID1C in rat primary cortical neurons suppresses dendritic growth (Iwase et al., 2007).
Furthermore, both IL1RAPL1 and ATP6AP2, two XLMR genes, are reported to regulate
NGF-induced neurite extension in rat neuroendocine cell line PC12 cells (Contrepas et al.,
2009; Gambino et al., 2007). To investigate whether CUL4B has a function in neuronal cell
differentiation and if this function is dependent on WDR5, we made Cul4b stably knocked
down PC12 cells by transduction of retrovirus encoding rat Cul4b shRNA. Knockdown
Cul4b increased both Wdr5 mRNA (Figure S4C) and protein (Figure 5A, lower panel),
confirming the down-regulation of Wdr5 by Cul4b in rat neuroendocrine cells and also
suggesting the possibility that Wdr5 activates its own transcription. We treated PC12 cells
with nerve growth factor (NGF) and observed time-dependent neurite extension. We found
that NGF-induced neurite extension was suppressed by Cul4b knockdown (Figure 5A,
Figures S4A and S4B). To determine whether Wdr5 accumulation is responsible for this
effect, we made Cul4b and Wdr5 double knockdown cells and found that suppression of
neurite extension could be partially rescued by co-knockdown of Wdr5, restoring the neurite
extension to a level that is not significantly different from GFP control population (p=0.124)
(Figure 5A, Figure S4B). The reason that co-depletion of both Cul4b and Wdr5 resulted in
only partial instead of complete rescue is likely caused by too much decrease of WDR5.
Simultaneous knocking down both Cul4b and WDR5, instead of restoring WDR5 protein to
its normal level, decreased it to a level lower (by 17%) than that normally expressed in cells
(lower panel, Figure 5A), suggesting that WDR5 protein must be tightly regulated and
neither too high nor too low level of WDR5 is appropriate for neural differentiation. In
addition, overexpression of human WDR5, which is identical to rat Wdr5, suppressed NGF-
induced neurite extension (Figure 5B). These results demonstrate that Cul4b promotes
neurite extension by down-regulating Wdr5 protein.
XLMR-derived mutations impair the ability of CUL4B to degrade WDR5 and support neurite
extension of PC12 cells
Nine different mutations in CUL4B were identified from ten XLMR families and six caused
truncation of CUL4B, indicating a loss-of-function alteration (Badura-Stronka et al., 2010;
Tarpey et al., 2007; Zou et al., 2007). The three remaining are missense mutations, T213A,
R572C and V745A, whose effect on CUL4B are not clear. To determine this, we created
these three XLMR-derived CUL4B point mutants and first examined their function in
supporting NGF-induced neurite outgrowth of PC12 cells. Rat Cul4b protein is 96%
identical to human CUL4B, including the NLS and three missense XLMR mutations (Figure
S5A). We transduced PC12 cells with retrovurus expressing shRNA targeting rat Cul4b
alone or with retrovirus expressing wild type, XLMR-derived, or NLS mutant human
CUL4B that are resistant to the Cul4b shRNA. Treatment of these cells with NGF
demonstrate that neurite extension was suppressed by Cul4b knockdown and this
suppression was partially rescued by the ectopic expression of wild type CUL4B, but not
three XLMR-derived CUL4B mutants or the NLS mutant (Figure 6A, Figures S6B, S6C and
S6D). Consistent with this functional assay, immunoblot analyses revealed that Cul4b
knockdown increased Wdr5 protein and this increase is almost completely blocked by the
ectopic expression of wild type human CUL4B, but not three XLMR-derived CUL4B
mutants nor the NLS mutant. These results demonstrate that XLMR-derived mutations
significantly impaired the ability of CUL4B in promoting WDR5 degradation and in
supporting neurite extension of PC12 cells. Furthermore, these results also demonstrate that
nuclear localization of CUL4B is critical for the function of CUL4B in supporting PC12 cell
differentiation.
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XLMR-derived mutations disrupt CSN binding and destabilize CUL4B protein
To determine the mechanism by which XLMR-derived mutations impair the function of
CUL4B, we examined the binding of CUL4B with three essential subunits of CRL4 E3
complexes, ROC1, DDB1 and CSN5/JAB1. No significant effect was seen on the DDB1 or
ROC1 binding by any of three missense XLMR mutations, but both R572C and V745A
mutations clearly reduced the binding of CUL4B with CSN5, the catalytic subunit of COP9/
signalosome (CSN) complex that plays an essential function in the activation of CRL E3
complexes by promoting the cleavage of covalent linkage of NEDD8 from cullins (Wei et
al., 2008). R572 resides within the central region of CUL4B whose function, as is the case
for other cullins, has not been clearly defined and our finding thus suggests that this region
is involved in the binding with CSN complex. The V745 locates within the ROC1-binding
site. Interestingly, while V745A mutation had little effect on ROC1 binding, it severely
impaired the CSN5 binding. The exact mechanism underlying the disruption of CSN5-
CUL4B by the V745A mutation has not been determined, but deletion of a 6-residue
sequence in CUL1 that includes the equivalent Val residue has previously been noted to
disrupt Nedd8 modification and CUL1 function (Furukawa et al., 2000).
No obvious effect on DDB1, ROC1 or CSN5 binding was detected by T213I mutation.
Unlike R572 and V745, both of which are conserved in other cullins, T213 is only
conserved in between two CUL4, and no known function or subunit binding is known to
locate in this region. In searching for the mechanism underlying the impairment of CUL4B
function by T213I mutation, we noted that in repeated ectopic expression experiments,
CUL4BT213I mutant was consistently expressed at a lower level than the wild type CUL4B.
We therefore determined the mRNA level and protein stability of CUL4BT213I mutant. qRT-
PCR analyses demonstrated that the mRNA of CUL4BT213I and the other two XLMR
mutants were expressed at similar levels as both the wild type and NLS mutant of CUL4B
(Figure S5D), excluding the possibility of reduced mRNA stability by the XLMR mutations.
We then determined the half-life of different CUL4B mutants and found that the turnover of
three XLMR mutants of CUL4B was much faster than either wild type or NLS mutant
CUL4B (Figure 6B). The half-life of CUL4B was reduced from more than 6 h of the
experimental duration for wild type protein to 3.7 h by V745A mutation, 2.7 h by R572C
mutation and 1.8 h by T213I mutation. Treatment of cells with proteasome inhibitor resulted
in the accumulation of three XLMR mutants to a similar level as the wild type CUL4B
(Figure S5E), providing additional support for the destabilizing effects conferred by T213I
and the other two XLMR mutations. Together, these findings provide molecular
explanations—reduced CSN binding and activation and protein stability—for impaired
function of CUL4B.
DISCUSSION
CUL4 is one of three founding cullins conserved from yeast to humans. Genetic analyses in
various organisms have previously revealed a wide range of cellular and organismal
function of CUL4, with many of them associated with chromatin such as chromosomal
condensation, heterochromatin formation, DNA replication and repair. At least seven CRL4
substrates have thus far been identified in mammalian cells that are linked to DNA
metabolism, including DNA repair proteins DDB2 and XPC, histones H2A, H3 and H4,
DNA replication licensing factor CDT1 [reviewed in (Hannah and Zhou, 2009; Jackson and
Xiong, 2009)] and very recently histone H4 monomethylase PR-Set7 (Abbas et al., 2010;
Oda et al., 2010). Our finding that WDR5 is a substrate of CRL4B E3 ligase and that
CRL4B-mediated WDR5 degradation plays a critical function in the regulation of neural
gene expression (summarized in Figure 7) provides the first example where a CRL4 E3
ligase controls cell differentiation through targeting the ubiquitylation of a histone
modifying enzyme to regulate gene expression, providing new insight into the function of
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CUL4 in chromatin regulation. In addition to serving as an essential factor for H3K4
methyltransferases of MLL1 family, WDR5 is present in many other chromatin modifying
or transcriptional complexes, including NIF-1 histone methyltransferase complex (Garapaty
et al., 2009), ATAC histone acetyltransferase complex (Wang et al., 2008), RING1b histone
ubiquitin ligase complex (Sanchez et al., 2007), CHD8 chromatin remodeling complex (Dou
et al., 2005; Thompson et al., 2008), H1.2 transcriptional repressive complex (Kim et al.,
2008), and clock proteins PERIOD (PER)-mediated transcriptional repression (Brown et al.,
2005). As a result of such a broad function of WDR5, CRL4B may play even more
extensive roles in chromatin control and gene regulation. In fact, we observed that the levels
of acetyl-H4 (H4Ac) on those neuronal genes regulated by WDR5 was increased after
knocking down CUL4B and restored after co-depletion of both CUL4B and WDR5 (Figure
S3B).
The physiological condition(s) signaling WDR5 ubiquitylation by DDDB1-CUl4B-ROC1
remains to be elucidated. In NGF-treated PC12 cells, no significant change of the steady
state level of CRL4B components (Cul4b, Ddb1 and Roc1) nor WDR5 was observed,
indicating a constitutive, rather than an NGF-regulated degradation in this setting (Figure
S4D). We speculate that DDB1-CUL4B may function to regulate the homeostasis of WDR5
complexes. By maintaining a dynamic regulation of WDR5, cells can ensure continued
responsiveness of different WDR5 complexes to different growth conditions and signaling
pathways.
At the molecular level, CRL4B-meidated WDR5 ubiquitylation has two unique features—
ubiquitylating a DWD protein and functioning in a specific subcellular compartment.
DDB1-binding WD40 (DWD, or DCAF or CDW) proteins are believed to recognize and
recruit other substrates to the CUL4-ROC1 catalytic core for ubiquitylation. Our finding
indicates that DWD proteins themselves can be a direct substrate of CRL4 E3 ligase. Similar
observations have previously been made for F-box protein Cdc4 and BTB protein RhoBTB2
which are ubiquitylated and degraded by their associated CRL1 and CRL3 E3 ligases,
respectively (Wilkins et al., 2004; Zhou and Howley, 1998). How a CRL E3 ligase
distinguishes a protein being as a substrate recognition subunit or a substrate is an
interesting and important issue that is yet to be determined.
CUL4B-targeted WDR5 ubiquitylation occurs specifically in the nucleus. There have been
relatively few examples of localized ubiquitylation reported thus far. Two notable examples
are p53 and β-catenin, transcription factors that can be exported out of the nucleus for
degradation in the cytoplasm. This nuclear export and cytoplasmic ubiquitylation ensures
that the function of the transcription factor is geographically separated from its degradation
to avoid promiscuous degradation and to allow rapid activation of the factor in response to
signaling events by simply blocking export and ubiquitylation (Xiong, 2010). Our finding
provides another example of targeted ubiquitylation in a specific subcellular compartment,
but the significance of having the function and degradation of WDR5 in the same
compartment is unclear at present.
Mutations of as many as 90 genes have been linked to XLMR, a pathologically
heterogeneous disease that has thus far not been causally linked to one single clear or major
molecular or cellular defect. The finding reported here provides a mechanism—CRL4B-
mediated ubiquitylation and degradation of WDR5—for the cause of CUL4B mutations to
the development of XLMR. Supporting its function in normal brain development and
suppression of XLMR, Cul4b is highly expressed in the cerebrum and hippocampus of
mouse brain, both affected in mental retardation patients (Lein et al., 2007). It should be
pointed out that it is not clear whether the development of XLMR in CUL4B mutated cells
was mainly by the defects in WDR5 ubiquitylation or also involved additional substrates. It
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is worthwhile to note that there are two other XLMR-mutated genes, KDM5C/SMCX/
JARID1C which encodes a H3K4 demethylase and PHF8 which binds to tri-methylated
H3K4 to catalyze the demethylation of H3K9 (Iwase et al., 2007; Kleine-Kohlbrecher et al.,
2010; Qi et al., 2010; Qiu et al., 2010; Tahiliani et al., 2007). We demonstrate here that the
degradation of a core subunit of H3K4 methyltransferase, WDR5, is critically important for
the function of XLMR gene product CUL4B in the regulation of neural gene expression and
PC12 cell differentiation, as seen by the suppression of these defects in CUL4B knocking
down cells by the co-depletion of WDR5. This finding points to a common molecular defect
—abnormal activation of neural gene expression resulting from altered histone modification
—underlying these three otherwise biochemically unrelated XLMR genes, adding further to
the notion that mutations targeting a major part of XLMR genes deregulate epigentic
control. Recent genome-wide association study suggested that WDR5 is also one of the
candidate genes affecting general cognitive ability (Davis et al., 2010), suggesting that
CRL4B-mediated WDR5 ubiquitylation may be more broadly involved in learning and
memory.
EXPERIMENTAL PROCEDURES
Transfection and retroviral infection
Fugene 6 transfection reagent (Roche) or Lipofectamine 2000 reagent (Invitrogen) was used
for transient overexpression or transient knocking down by siRNA, respectively. The
retroviral production and transduction were performed as previously described (Kotake et
al., 2007). A detailed description of the experimental procedures is available in the
Supplemental Experimental Procedures. Target sequences of siRNAs are shown in Table S1.
Plasmid Construction
Expression constructs of human cullins and ubiquitin were previously described (Hu et al.,
2008; Michel and Xiong, 1998). Expression construct of human WDR5 was kindly provided
by Dr. Yali Dou (University of Michigan, Ann Arbor, MI). shRNA construct for human
WDR5 was previously described (Kotake et al., 2009). A detailed description of other
expression constructs is available in the Supplemental Experimental Procedures. Target
sequences of shRNA constructs for human CUL4B, rat Cul4b, rat Wdr5, rat p19Ink4d are
described in Table S1.
Nuclear/cytosolic and chromatin fractionation
A detailed description of the experimental procedures is available in the Supplemental
Experimental Procedures.
Immunoprecipitation and Immunoblotting
A detailed description of the experimental procedures is available in the Supplemental
Experimental Procedures.
Ubiquitination assays
In vivo and in vitro ubiquitination assays were performed as described previously (Liu et al.,
2002, Furukawa et al., 2003, Hu et al., 2004, Kaneko-Oshikawa et al., 2005). For in vitro
ubiquitination assay, WDR5 was produced by bacteria and CRL4B complex was purified
from HEK293T cells. A detailed description of the experimental procedures is available in
the Supplemental Experimental Procedures.
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293T cells were transfected with CUL4B constructs, treated with cycloheximide (100 µg /
ml), and then subjected to immunoblot analysis. A detailed description of the experimental
procedures is available in the Supplemental Experimental Procedures.
Quantitative reverse-transcription PCR (qRT-PCR)
qRT-PCR was performed as previously described (Kotake et al., 2009). PCR primers used in
this study are summarized in Table S3.
Chromatin Immunoprecipitation assay
Chromatin Immunoprecipitation assay was performed as previously described (Kotake et al.,
2009). Antibodies and PCR primers used in this study are summarized in Table S2 and
Table S4, respectively.
PC12 Neurite Extension Assay
PC12 Neurite Extension assay was performed as previously described with some
modifications (Bai et al., 2005; Greene, 1978; Saita et al., 2009). A detailed description of
the experimental procedures is available in the Supplemental Experimental Procedures.
Immunofluorescence Staining
U2OS cells were fixed and incubated with lab-made anti-myc antibody, followed by
incubated with rhodamine-labeled secondary antibody. After washing, 5 µg/ml 4’,6-
diamidino-2-phenylindole (DAPI) was treated and cells were examined with fluorescence
microscope. A detailed description of the experimental procedures is available in the
Supplemental Experimental Procedures.
Highlights
CRL4B is a nuclear E3 ligase and targets WDR5 for ubiquitylation and degradation
CUL4B controls WDR5 and H3K4me3 on the neuronal gene promoters
CUL4B is required for NGF-induced neurite extension
XLMR mutations destabilize CUL4B and impair its ability in neurite extension
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CRL4B degrades WDR5 protein in a proteasome dependent manner
(A) HCT116 cells were transiently transfected with siRNA for DDB1. Cells were harvested
every other day (up to 6 days), and cell lysates were subjected to immunoblot analysis (IB)
with indicated antibodies.
(B, C) HCT116 cells were transiently transfected with indicated siRNA. Cells were
harvested, and cell lysates were subjected to immunoblot analysis (IB) with indicated
antibodies (C) or qRT-PCR analysis to determine the WDR5 mRNA levels in cells 4 days
post-transfection (B). Band intensity was measured by NIH Image J (version 1.44k).
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(D) HCT116 cells were transiently transfected with siRNA targeting CUL4B. 3 days later,
cells were treated with cycloheximide for indicated time and harvested. Cell lysates were
subjected to immunoblot analysis (IB) with indicated antibodies.
(E) HCT116 cells were transiently transfected with an expression vector for myc-tagged
cullin family members and harvested 2 days later. Cell lysates were subjected to
immunoblot analysis (IB) with indicated antibodies.
(F) 293T cells were transiently transfected with an expression vector for myc-tagged
CUL4B and treated with MG132 two days later for 6 hours before harvested. Cell lysates
were subjected to immunoblot analysis (IB) with indicated antibodies.
See also Figure S1.
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Figure 2. WDR5 is ubiquitinated by CRL4B in vivo and in vitro
(A) HCT116 cells transfected with indicated plasmids were lysed and subjected to
immunoprecipitation (IP) with antibody to WDR5 under denaturing condition. The resulting
precipitates were subjected to western analysis (IB) with antibodies to HA or to WDR5. A
portion of the input lysates was also subjected directly to immunoblot analysis with
antibodies to myc or tubulin.
(B) HCT116 cells transfected with plasmids for HA-ubiquitin along with siRNA targeting
DDB1, CUL4A or CUL4B were lysed and subjected to immunoprecipitation (IP) and
immunoblot analysis (IB) as in (A).
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(C) Recombinant WDR5 was incubated with different combinations of E1, E2 and CRL4B
(E3) along with ubiquitin and ATP. Reactants were subjected to immunoblot analysis (IB)
with indicated antibodies.
(D) Lysates of HEK293T cells treated with MG132 for 6 hours were subjected to
immunoprecipitation with indicated antibodies and the resulting precipitates, as well as a
portion (10% of the input for immunoprecipitation) of the cell lysates, were subjected to
immunoblot analysis (IB) with indicated antibodies.
(E) HEK293T cells were transiently transfected with indicated vectors, treated with MG132
for 6 hours and harvested. Protein bindings were determined by IP-western analysis using
indicated antibodies.
Nakagawa and Xiong Page 17













Figure 3. Nuclear localization of CUL4B is critical for degrading WDR5
(A) Schematic illustration comparing human CUL4A and CUL4B proteins. DDB1 and
ROC1 binding regions conserved in both proteins and an NLS (55KKRK58) unique to
CUL4B are indicated.
(B) U2OS cells were transiently transfected with an expression vector for myc-tagged wild
type CUL4B or NLS mutant CUL4B, and the cells were fixed and immunostained with anti-
myc antibody. Nucleus was visualized by DAPI. Scale bar, 10 µm.
(C) HEK293T cells transiently transfected with plasmid expressing myc-tagged wild type
CUL4B or NLS mutant CUL4B were lysed and subjected to immunoblot analysis (IB).with
indicated antibodies.
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(D) HEK293T cells were transiently transfected with plasmid expressing indicated proteins.
The steady state levels of individual ectopically expressed protein and endogenous WDR5
were determined by immunoblot analysis (IB).
(E) Cytosolic and nuclear fractions of PC12 cells were subjected to immunoblot analysis
(IB) with indicated antibodies.
(F) Nuclear extract of PC12 cells were subjected to IP-western analysis for the association
of CUL4B with WDR5.
See also Figure S2.
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Figure 4. Knocking-down CUL4B abnormally activate neuronal gene expression in a WDR5
dependent manner
(A) HeLa cells were transduced with retrovirus encoding shRNA targeting GFP (control),
CUL4B or WDR5, and selected by puromycin treatment. DNA/protein complexes were
crosslinked, and subjected to ChIP analysis with a WDR5 antibody. Immunoprecipitates
were analyzed by quantitative PCR (qPCR) using primers for indicated neuronal gene
promoters (left panel). Global level of WDR5 and several other proteins were determined by
immunoblotting (IB) using indicated antibodies (right panel).
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(B) ChIP and immunoblotting (IB) was performed with anti-H3K4me3 antibody as in (A).
Chromatin fractions were used for immunoblotting to determine nucleosomal H3K4me3
level.
(C) RNA from the same cells as in (A) and (B) was isolated, reverse-transcribed and
quantitative PCR (RT-qPCR) were performed using primers for indicated neuronal genes.
Error bars represent S.E. from three independent experiments. * indicates p<0.05 and **
indicate p<0.01 by t test.
See also Figure S3.
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Figure 5. Knockdown of Cul4b suppresses NGF-induced neurite elongation of PC12 cells in a
Wdr5 dependent manner
(A) PC12 cells were infected with retrovirus encoding shRNA for GFP, Cul4b, Wdr5 or
p19Ink4d and infected cells were selected by puromycin treatment. Neurite-extending cells
were counted 4 days after NGF treatment (upper panel) or cells were lysed and subjected to
immunoblot analysis (IB) with indicated antibodies (lower panel).
(B) PC12 cells were infected with retrovirus encoding Flag-WDR5-HA, and infected cells
were selected by puromycin treatment. Neurite extension and immunoblot analysis were
performed as in (A).
Error bars represent S.E. from three independent experiments. Band intensity was measured
by NIH Image J (version 1.44k). p values were measured by t test.
See also Figure S4.
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Figure 6. XLMR patients-derived CUL4B mutants cannot rescue Cul4b knockdown phenotype
(A) PC12 cells were transduced with retrovirus encoding wild type or mutants CUL4B along
with retrovirus encoding shRNA targeting Cul4b, and transduced cells were selected by
puromycin treatment. Neurite-extending cells were counted 4 days after NGF treatment
(upper panel) or protein expression was determined by immunoblot analysis (lower panel).
Error bars represent S.E. from three independent experiments. ** indicate p<0.01 by t test.
(B) HEK293T cells were transiently transfected with an expression vector for myc-tagged
wild type or mutant CUL4B. The expression of ROC1, DDB1 and CSN5 (upper panel) and
their binding with wild type or mutant CUL4B (lower panel) were determined by direct
immunoblotting or IP-western analysis using indicated antibodies.
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(C) HEK293T cells were transiently transfected with an expression vector for myc-tagged
wild type or mutant CUL4B and treated with cycloheximide for indicated time. Cell lysates
were subjected to immunoblot analysis (IB) with indicated antibodies. Band intensity was
measured by NIH Image J (version 1.44k).
See also Figure S5.
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Figure 7. Schematic representation of our finding
CRL4B E3 ligase targets WDR5 ubiquitylation in the nucleus and regulates neuronal gene
expression. See Discussion for details.
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